About oral mucositis

What is oral mucositis?

What causes oral mucositis?

How may oral mucositis affect my cancer treatment?

References

Note: All the references are available on request to EUSA Pharma

1. Sonis S et al. J Clin Oncol 2001;19:2201–2205
2. Sonis S et al. Cancer 2004;100(Suppl 9):1995–2025
3. Avritscher EB et al. Semin Oncol Nurs 2004;20:3–10
4. Anthony L et al. Support Care Cancer 2006;14:516–518
5. Redding SW. J Dent Educ 2005;69:919–929

This website contains information about Oral Mucositis and the use of Caphosol for the prevention and treatment of Oral Mucositis
Caphosol is a class I medical device, marked CE

©EUSA Pharma (Europe) Ltd. May 2009. All rights reserved. www.eusapharma.com
Registered in England 4555273 Registered Office The Magdalen Centre, Oxford Science Park, Oxford OX4 4GA Vat Registration No: 896 1192 88

www.caphosol.eu